ARCHIVES

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

This article is from The Cancer Letter archive.

Vol. 28 No. 44 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Lasker Foundation Will Not Make 1990 Awards; Michigan Cancer Elects Fischer Vice Chairman

March 2, 1990

Surgeon General plans new report, database, on tobacco.

January 16, 2004

Long-term Hormonal Therapy Adds No Additional Benefits

September 27, 2013

Cancer Control Reps Discuss Issues of ‘80s

October 17, 1980

ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated

March 12, 1999

Advisors Approve New Grant Programs In Breast Pre-Malignancy, Lung Inflammation

November 17, 2006